← Back to catalogue

LipidPlus® Meter

FDA UDI

Class I (US FDA UDI)

by Jant Pharmacal Corp.

Identity

Trade Name
LipidPlus® Meter FDA UDI
Generic Name
Glycated haemoglobin (HbA1c) monitoring system IVD, home-use FDA UDI
Device Name
Lipid and Glucose Measuring System FDA UDI
Model / Reference
MD550 FDA UDI
Description
Lipid and Glucose Measuring System FDA UDI

Identifiers

Primary DI / UDI-DI
10763924550507 FDA UDI
FDA Product Code
JJX FDA UDI
LBR FDA UDI
JGY FDA UDI
CHH FDA UDI
CGA FDA UDI
NBW FDA UDI
GMDN Term
Glycated haemoglobin (HbA1c) monitoring system IVD, home-use FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
862.1475 FDA UDI
862.1705 FDA UDI
862.1175 FDA UDI
862.1345 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Glycated haemoglobin (HbA1c) monitoring system IVD, home-useGlycated haemoglobin (HbA1c) monitoring system IVD, point-of-careHome-use/point-of-care blood glucose/ketone monitoring system IVD

LipidPlus® Meter by Jant Pharmacal Corp. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glycated haemoglobin (HbA1c) monitoring system IVD, point-of-care.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 9162d105-0f41-4cbc-a103-a37397979360 34 fields · synced May 31, 2026